non-financial development institution
major organizer of congress and exhibition events
Welcome!
Восстановление пароля
Введите адрес электронной почты или телефон, указанные при регистрации. Вам будет отправлена инструкция по восстановлению пароля.
Некорректный формат электронной почты или телефона
Вегнер Макс
Max Wegner
Senior Vice President, Head of Regulatory Affairs, Pharmaceuticals Division, Bayer AG
Quotes
07.06.2019
SPIEF 2019
Creating innovative medicines and new horizons in healthcare
We see large innovative potential in Russia. <...> We are all headed the same way, basically: towards the technologies of the future to benefit our patients
07.06.2019
SPIEF 2019
Innovative development of the pharmaceutical and biotech industry in Russia: keys to success
Russia is an important market for us. It has a great potential and it is full of innovative projects. For example, Almazov Centre
07.06.2019
SPIEF 2019
Innovative development of the pharmaceutical and biotech industry in Russia: keys to success
Russia has fairly limited opportunities to speed up product launch. There is Fast Track in Europe and the US: it is a set of initiatives that help with a fast market launch